| Stage | ADBE | % of rev | ADSK | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $6.8B | 100.00% | $2.0B | 100.00% | ADBE ×3.30 |
| Gross profit | $6.0B | 88.71% | $1.9B | 91.40% | ADSK +2.7pp |
| Operating income | $2.4B | 34.82% | $599M | 29.28% | ADBE +5.5pp |
| Pre-tax income | $2.4B | 34.87% | $593M | 28.98% | ADBE +5.9pp |
| Net income | $1.8B | 27.03% | $492M | 24.05% | ADBE +3.0pp |
| Stage | ADBE | ADSK | Gap · A − B |
|---|---|---|---|
| Revenue | $6.8B100.00% | $2.0B100.00% | ADBE ×3.30 |
| Gross profit | 88.71%$6.0B | 91.40%$1.9B | ADSK +2.7pp |
| Operating income | 34.82%$2.4B | 29.28%$599M | ADBE +5.5pp |
| Pre-tax income | 34.87%$2.4B | 28.98%$593M | ADBE +5.9pp |
| Net income |
| 27.03%$1.8B |
| 24.05%$492M |
| ADBE +3.0pp |
No shared counterparties.